Table 1 Characteristics of the study participants
| Â | ANTgroup (N=36) | NonANT group (N=33) | Control group (N=44) |
|---|---|---|---|
Sex M/F | 19/17 | 16/17 | 22/22 |
Diagnosis | ALL (33) | ALL (33) | Â |
(No. of pts) | AML (3) | Â | Â |
Age at diagnosis, yrs | 8 (1–17) | 5 (2–10) |  |
Median (range) | Â | Â | Â |
Time since completion of therapy, yrs Median (range) | 11 (5–22) | 15 (6–25) |  |
Age at time of the study, yrs | 22 (18–31) | 23 (17–31) | 23 (20–28) |
Median (range) | Â | Â | Â |
Chemotherapy | Doxorubicin | Cyclophosphamide Vincristine | Â |
| Â | Daunorubicin | L-Asparaginase | Â |
| Â | Epirubicin | Methotrexate | Â |
| Â | Â | 6-Mercaptopurine | Â |